CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 294 filers reported holding CANTEL MEDICAL CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $501,000 | -50.8% | 6,275 | -51.5% | 0.01% | -35.7% |
| Q4 2020 | $1,019,000 | +78.5% | 12,927 | +0.2% | 0.01% | +75.0% |
| Q3 2020 | $571,000 | 0.0% | 12,907 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $571,000 | +22.3% | 12,907 | -0.8% | 0.01% | +14.3% |
| Q1 2020 | $467,000 | -38.5% | 13,011 | +21.6% | 0.01% | -50.0% |
| Q4 2019 | $759,000 | -3.2% | 10,701 | +2.1% | 0.01% | -17.6% |
| Q3 2019 | $784,000 | -6.2% | 10,479 | +1.1% | 0.02% | -15.0% |
| Q2 2019 | $836,000 | +93.5% | 10,363 | +60.5% | 0.02% | +150.0% |
| Q1 2019 | $432,000 | -15.5% | 6,458 | -5.9% | 0.01% | -11.1% |
| Q4 2018 | $511,000 | -18.9% | 6,861 | +0.3% | 0.01% | -10.0% |
| Q3 2018 | $630,000 | -8.0% | 6,839 | -1.9% | 0.01% | 0.0% |
| Q2 2018 | $685,000 | -15.4% | 6,968 | -4.2% | 0.01% | -23.1% |
| Q1 2018 | $810,000 | – | 7,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,805,250 | $61,144,000 | 18.90% |
| Brown Capital Management | 4,069,141 | $137,822,000 | 2.95% |
| Kimelman & Baird, LLC | 364,514 | $12,346,000 | 2.60% |
| Teton Advisors, Inc. | 396,782 | $13,439,000 | 1.18% |
| Ranger Investment Management | 565,995 | $19,170,000 | 0.93% |
| Geller Advisors LLC | 26,043 | $882,000 | 0.75% |
| CONNORS INVESTOR SERVICES INC | 57,826 | $1,959,000 | 0.63% |
| Boston Trust Walden Corp | 733,798 | $24,853,000 | 0.40% |
| MISSOURI VALLEY PARTNERS, INC. | 24,481 | $829,000 | 0.32% |
| GENEVA CAPITAL MANAGEMENT LLC | 451,958 | $15,307,000 | 0.31% |